Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2020; 10(15):6629-6637. doi:10.7150/thno.47849 This issue Cite

Research Paper

Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery

Sheng Wang1,✉, Fuwu Zhang3, Guocan Yu3, Zhantong Wang3, Orit Jacobson3, Ying Ma3, Rui Tian3, Hongzhang Deng3, Weijing Yang3, Zhi-Yi Chen2,✉, Xiaoyuan Chen3,✉

1. School of Life Sciences, Tianjin University and Tianjin Engineering Center of Micro-Nano Biomaterials and Detection-Treatment Technology, Tianjin 300072, China
2. Department of Ultrasound Medicine, Laboratory of Ultrasound Molecular Imaging, The Third Affiliated Hospital of Guangzhou Medical University, The Liwan Hospital of the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, China
3. Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892, United States

✉ Corresponding authors: shengwangedu.cn, winchen126.com, shawn.chengov

Citation:
Wang S, Zhang F, Yu G, Wang Z, Jacobson O, Ma Y, Tian R, Deng H, Yang W, Chen ZY, Chen X. Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery. Theranostics 2020; 10(15):6629-6637. doi:10.7150/thno.47849. https://www.thno.org/v10p6629.htm
Other styles

File import instruction

Abstract

Graphic abstract

Zwitterionic surface modification is a promising strategy for nanomedicines to achieve prolonged circulation time and thus effective tumor accumulation. However, zwitterion modified nanoparticles suffer from reduced cellular internalization efficiency.

Methods: A polyprodrug-based nanomedicine with zwitterionic-to-cationic charge conversion ability (denoted as ZTC-NMs) was developed for enhanced chemotherapeutic drug delivery. The polyprodrug consists of pH-responsive poly(carboxybetaine)-like zwitterionic segment and glutathione-responsive camptothecin prodrug segment.

Results: The ZTC-NMs combine the advantages of zwitterionic surface and polyprodrug. Compared with conventional zwitterionic surface, the ZTC-NMs can respond to tumor microenvironment and realize ZTC surface charge conversion, thus improve cellular internalization efficiency of the nanomedicines.

Conclusions: This ZTC method offers a strategy to promote the drug delivery efficiency and therapeutic efficacy, which is promising for the development of cancer nanomedicines.

Keywords: charge conversion, zwitterionic, polyprodrug, triggered drug release, nanomedicine

Citation styles

APA
Wang, S., Zhang, F., Yu, G., Wang, Z., Jacobson, O., Ma, Y., Tian, R., Deng, H., Yang, W., Chen, Z.Y., Chen, X. (2020). Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery. Theranostics, 10(15), 6629-6637. https://doi.org/10.7150/thno.47849.

ACS
Wang, S.; Zhang, F.; Yu, G.; Wang, Z.; Jacobson, O.; Ma, Y.; Tian, R.; Deng, H.; Yang, W.; Chen, Z.Y.; Chen, X. Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery. Theranostics 2020, 10 (15), 6629-6637. DOI: 10.7150/thno.47849.

NLM
Wang S, Zhang F, Yu G, Wang Z, Jacobson O, Ma Y, Tian R, Deng H, Yang W, Chen ZY, Chen X. Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery. Theranostics 2020; 10(15):6629-6637. doi:10.7150/thno.47849. https://www.thno.org/v10p6629.htm

CSE
Wang S, Zhang F, Yu G, Wang Z, Jacobson O, Ma Y, Tian R, Deng H, Yang W, Chen ZY, Chen X. 2020. Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery. Theranostics. 10(15):6629-6637.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use